On CNBC's “Mad Money Lightning Round,” on Thursday, Jim Cramer said Recursion Pharmaceuticals (NASDAQ: RXRX) has been “horrendous” and he does not like to recommend horrendous stocks. On the earnings ...

A small-scale artificial-intelligence model that learns from only a limited pool of data is exciting researchers for its potential to boost reasoning abilities. The model, known as Tiny Recursive ...

Abstract: The generation of electrical energy from renewable energy sources (RESs) has increased over the past few decades as part of efforts to reduce humanity's environmental impact. However, their ...

Recursion Pharmaceuticals Inc. (NASDAQ:RXRX) stock is surging on Wednesday, without any news to justify the movement. Session volume stands at 69.3 million versus the average volume of 26.9 million, ...

This week, I had to make one of the most difficult decisions of my career: saying goodbye to 20% of the team at Recursion. The process was extraordinarily painful, and the costs were heartbreakingly ...

James is a published author with multiple pop-history and science books to his name. He specializes in history, space, strange science, and anything out of the ordinary.View full profile James is a ...

Hi, I have been using lsp-ai so far successfully with Ollama, but now wanted to try Gemini - since the free tier is quite generous. I am having a weird problem though, where the \n characters are ...

Large Language Models (LLMs) benefit significantly from reinforcement learning techniques, which enable iterative improvements by learning from rewards. However, training these models efficiently ...

Abstract: We observe that the computational inefficiency of branched recursive functions was not appropriately covered in almost all textbooks for computer science courses in the first three years of ...

In this week’s edition of InnovationRx, we look at a new biotech fund spearheaded by Recursion, a shift in bird flu strategy from the Trump Administration, a new vaccine approval from the FDA, ...